In a Subgroup of High-Risk Asians, Telmisartan Was Non-Inferior to Ramipril and Better Tolerated in the Prevention of Cardiovascular Events

• Antonio L. Dans ,

  * E-mail: tdans@skybroadband.com.ph

  Affiliation University of the Philippines College of Medicine, Manila, Philippines

  ⨯
• Koon Teo,

  Affiliation Population Health Research Institute, McMaster University, Hamilton, Canada

  ⨯
• Peggy Gao,

  Affiliation Population Health Research Institute, McMaster University, Hamilton, Canada

  ⨯
• Jyh-Hong Chen,

  Affiliation National Cheng Kung University Medical College, Tainan, Taiwan

  ⨯
• Kim Jae-Hyung,

  Affiliation St. Paul's Hospital, The Catholic University of Korea, Seoul, Korea

  ⨯
• Khalid Yusoff,

  Affiliation Universiti Teknologi MARA, Shah Alam, Malaysia

  ⨯
• Suphachai Chaithiraphan,

  Affiliation Chaophya Hospital, Bangkok, Thailand

  ⨯
• Jun Zhu,

  Affiliation FuWai Hospital, Chinese Academy of Medical Science, Beijing, China

  ⨯
• Liu Lisheng,

  Affiliation FuWai Hospital, Chinese Academy of Medical Science, Beijing, China

  ⨯
• Salim Yusuf,

  Affiliation Population Health Research Institute, McMaster University, Hamilton, Canada

  ⨯
• for the ONTARGET INVESTIGATORS